Institutional investors hold a majority ownership of DEPO through the 78.17% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended June 2014, these large investors purchased a net $2.1 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SSGA FUNDS MANAGEMENT, INC. Bought 1.3 Million shares of Depomed Inc